Chemerin in immunity
Journal of Leukocyte Biology · 2025
DOI: 10.1093/jleuko/qiae181 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Journal of Leukocyte Biology, 2025. Verfasst von Mattia Laffranchi und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur-Fondazione Cenci Bolognetti, Viale Regina El…. Hauptthemen laut MEDLINE: Chemokines, Intercellular Signaling Peptides and Proteins, Immunity. Die Arbeit wurde bisher 33-mal zitiert (Crossref) und nennt 145 Literaturangaben. Gefördert von: Italian Association for Cancer Research, Ministero dell'Istruzione, dell'Università e della Ricerca, Ministero dell’Istruzione, dell’Università e della Ricerca.
Abstract (Originalsprache)
Chemerin is a distant member of the cystatin protein family, initially discovered as a chemotactic factor and subsequently also reported to act as adipokine and angiogenetic factor. The biological activity of chemerin is regulated at different levels, such as gene expression, protein processing, and interaction with both signaling and nonsignaling receptors. Chemerin is mostly produced by stromal cells, such as adipocytes, fibroblasts, and epithelial and endothelial cells, and circulates in almost all human tissues as a zymogen that needs to be proteolytically activated to exert its biological functions. At the receptor level, chemerin binds a G protein-coupled 7-transmembrane domain receptor Chemerin1 (also named ChemR23 and CMKLR1), mostly expressed by innate immune cells, such as macrophages, dendritic cells, and natural killer cells, and by border cells. In addition, chemerin may bind GPR1, a weak signaling receptor, and CCRL2, a nonsignaling receptor expressed by barrier cells, such as endothelial and epithelial cells, able to regulate leukocytes’ migration by multiple mechanisms. The aim of this review is to summarize the contribution of chemerin in the regulation of immune responses.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular Medicine, Sapienza University of Rome, Laboratory Affiliated to Istituto Pasteur-Fondazione Cenci Bolognetti, Viale Regina Elena 291, 00161 Rome, Italy.
- Department of Molecular and Translational Medicine, University of Brescia, Viale Europa 11, 25123 Brescia, Italy.
- IRCCS Humanitas Research Hospital, Via Manzoni 56, 20089 Rozzano, Milan, Italy.
- Department of Public Health and Pediatrics, University of Torino, Via Santena 9, 10126 Turin, Italy.
ORCID-Profile: Annalisa Del Prete
Förderung
- Italian Association for Cancer Research
- Ministero dell'Istruzione, dell'Università e della Ricerca
- Ministero dell’Istruzione, dell’Università e della Ricerca
Zitieren
APA
Laffranchi, M., Schioppa, T., Sozio, F., Piserà, A., Tiberio, L., Salvi, V., Bosisio, D., Musso, T., Sozzani, S., & Del Prete, A. (2025). Chemerin in immunity. Journal of Leukocyte Biology. https://doi.org/10.1093/jleuko/qiae181
Vancouver
Laffranchi M, Schioppa T, Sozio F, Piserà A, Tiberio L, Salvi V, et al. Chemerin in immunity. Journal of Leukocyte Biology. 2025. doi:10.1093/jleuko/qiae181
BibTeX
@article{Laffranchi2025,
author = {Laffranchi, Mattia and Schioppa, Tiziana and Sozio, Francesca and Piserà, Arianna and Tiberio, Laura and Salvi, Valentina and Bosisio, Daniela and Musso, Tiziana and Sozzani, Silvano and Del Prete, Annalisa},
title = {Chemerin in immunity},
journal = {Journal of Leukocyte Biology},
year = {2025},
doi = {10.1093/jleuko/qiae181}
}
EUVIMED